tradingkey.logo
tradingkey.logo
Search

Cue Biopharma Inc

CUE
Add to Watchlist
33.130USD
-1.070-3.13%
Close 07-23 16:00ETQuotes delayed by 15 min
2.58BMarket Cap
LossP/E TTM

CUE Financials

See Cue Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cue Biopharma Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-32.31/-0.11
Revenue / Forecast
5.69M/2.50M
Period
FY2025 Earnings
Revenue(YoY)
27.47M
195.75%
EPS(YoY)
-8.42
-1066.66%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-19474.79%-32.31
444.72%0.44
56.32%-0.07
56.17%-0.09
33.87%-0.17
55.18%-0.13
28.79%-0.17
31.13%-0.20
14.98%-0.25
23.57%-0.28
---0.24
---0.29
---0.29
---0.37
---1.11
----
----
----
----
----
Revenue
1250.59%5.69M
1292.26%21.94M
-35.58%2.15M
11.14%2.95M
-75.48%421.00K
-13.45%1.58M
58.86%3.34M
92.33%2.66M
818.18%1.72M
1104.15%1.82M
2988.24%2.10M
5215.38%1.38M
-81.30%187.00K
-98.17%151.23K
-97.16%68.00K
-99.05%26.00K
-35.61%1.00M
1636.57%8.25M
240.20%2.40M
154.79%2.74M
Net Profit
57.75%-5.18M
116.69%1.58M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
29.31%-9.50M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-74.05%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
24.49%-8.38M
-29.53%-12.99M
5.11%-10.28M
Net Margin
96.87%-91.07%
101.20%7.22%
-33.51%-346.58%
24.96%-287.14%
-304.87%-2911.40%
18.33%-602.54%
50.46%-259.59%
59.89%-382.66%
89.74%-719.10%
92.35%-737.73%
---524.05%
---954.05%
---7010.16%
---9649.32%
---3511.70%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-100.00%0.00%
-100.00%0.00%
-55.89%5.21%
-56.64%6.40%
13.50%15.16%
1.43%13.46%
-10.84%11.81%
7.14%14.76%
8.68%13.36%
21.16%13.27%
--13.24%
--13.78%
--12.29%
--10.95%
--13.05%
----
----
----
----
----
Revenue
1250.59%5.69M
1292.26%21.94M
-35.58%2.15M
11.14%2.95M
-75.48%421.00K
-13.45%1.58M
58.86%3.34M
92.33%2.66M
818.18%1.72M
1104.15%1.82M
2988.24%2.10M
5215.38%1.38M
-81.30%187.00K
-98.17%151.23K
-97.16%68.00K
-99.05%26.00K
-35.61%1.00M
1636.57%8.25M
240.20%2.40M
154.79%2.74M
Operating profit
56.39%-5.36M
120.33%1.96M
15.35%-7.54M
16.84%-8.63M
2.91%-12.30M
29.59%-9.63M
21.95%-8.91M
23.19%-10.38M
5.32%-12.67M
8.13%-13.68M
-3.52%-11.42M
-1.27%-13.52M
6.03%-13.38M
-88.58%-14.88M
15.26%-11.03M
-29.55%-13.35M
-13.74%-14.24M
28.08%-7.89M
-28.50%-13.02M
5.84%-10.30M
Net Profit
57.75%-5.18M
116.69%1.58M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
29.31%-9.50M
21.31%-8.66M
22.86%-10.17M
5.81%-12.35M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-74.05%-14.59M
15.69%-10.96M
-28.49%-13.21M
-13.99%-14.26M
24.49%-8.38M
-29.53%-12.99M
5.11%-10.28M
Current assets
65.66%26.39M
47.12%36.98M
-30.70%25.82M
-9.01%30.84M
-64.34%15.93M
-51.14%25.14M
-35.23%37.26M
-44.37%33.90M
-35.03%44.67M
-33.34%51.45M
-6.78%57.52M
-11.69%60.94M
-9.47%68.75M
12.73%77.19M
-12.18%61.70M
-13.40%69.00M
-1.88%75.95M
-21.78%68.47M
-24.91%70.25M
-9.82%79.68M
Total current liabilities
-52.31%7.39M
-1.42%13.49M
-7.54%15.52M
16.98%19.25M
-14.33%15.50M
-19.86%13.69M
-2.42%16.79M
0.93%16.46M
30.99%18.09M
47.91%17.08M
68.33%17.21M
95.93%16.31M
21.02%13.81M
-9.69%11.55M
-33.43%10.22M
-50.08%8.32M
-31.40%11.41M
-21.62%12.79M
7.93%15.36M
12.19%16.67M
Total assets
38.75%30.88M
31.13%42.21M
-29.38%31.64M
-3.83%40.71M
-58.75%22.25M
-47.68%32.19M
-34.95%44.81M
-42.14%42.33M
-33.95%53.95M
-32.59%61.53M
-9.71%68.89M
-13.67%73.16M
-9.95%81.68M
9.45%91.28M
-3.26%76.30M
-5.49%84.75M
2.24%90.70M
-16.21%83.40M
-26.02%78.88M
-11.53%89.67M
Total liabilities
-40.86%9.27M
7.41%15.78M
-5.38%18.40M
8.89%22.55M
-34.45%15.67M
-39.90%14.69M
-25.85%19.44M
-23.76%20.71M
-10.32%23.91M
-4.51%24.45M
2.69%26.22M
8.67%27.16M
2.44%26.66M
42.95%25.60M
66.30%25.54M
49.11%24.99M
36.63%26.03M
-13.16%17.91M
-19.46%15.36M
-20.93%16.76M
Total equity
228.39%21.61M
51.05%26.43M
-47.78%13.25M
-16.02%18.16M
-78.09%6.58M
-52.81%17.50M
-40.55%25.37M
-53.00%21.62M
-45.40%30.04M
-43.54%37.09M
-15.95%42.67M
-23.01%46.00M
-14.93%55.02M
0.29%65.68M
-20.08%50.76M
-18.04%59.76M
-7.17%64.67M
-17.01%65.49M
-27.45%63.52M
-9.04%72.91M
Net operating income
-33.90%-10.94M
88.08%-1.08M
-19.89%-9.02M
65.82%-3.42M
16.48%-8.17M
17.61%-9.03M
3.49%-7.53M
3.67%-9.99M
9.68%-9.78M
-4.22%-10.96M
-13.51%-7.80M
19.28%-10.37M
6.39%-10.83M
1.23%-10.51M
-3.68%-6.87M
-31.50%-12.85M
1.88%-11.57M
-52.09%-10.65M
13.79%-6.63M
-42.34%-9.77M
Net investment
19.33%-121.00K
702100.00%7.02M
-7006.12%-6.77M
-170.00%-27.00K
-172.73%-150.00K
---1.00K
-98.04%98.00K
-100.20%-10.00K
-100.37%-55.00K
-100.00%0.00
116.94%5.00M
8164.52%5.00M
55662.96%15.00M
978201.96%5.00M
-268263.64%-29.52M
73.39%-62.00K
-100.29%-27.00K
-99.99%511.00
-100.24%-11.00K
-66.43%-233.00K
Net financing
130.60%306.00K
1118.45%9.49M
-99.99%1.00K
1879.80%17.80M
-142.48%-1.00M
-119.49%-932.00K
114.01%9.82M
-147.60%-1.00M
506.70%2.35M
-82.55%4.78M
51088.89%4.59M
-81.09%2.10M
-97.44%388.00K
271.20%27.40M
-102.56%-9.00K
4.15%11.11M
1717.27%15.16M
2922.28%7.38M
-97.66%351.00K
-75.38%10.67M

FAQs

What is the total revenue of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its total revenue reached 27.47M, with a year-on-year change of 9.29M.

What are the current assets of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its current assets were 36.98M, with a year-on-year change of 47.12.

What are the total assets of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its total assets of Cue Biopharma Inc were 42.21M, with a year-on-year change of 31.13.

What are the total liabilities of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its total liabilities of Cue Biopharma Inc were 15.78M, with a year-on-year change of 7.41.

What is the total equity of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its total equity of Cue Biopharma Inc was 26.43M, with a year-on-year change of 51.05.

What is the net operating income of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its net operating income of Cue Biopharma Inc was -26.52M, with a year-on-year change of 36.24.

What is the net investment of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its net investment of Cue Biopharma Inc was 75.00K, with a year-on-year change of 134.38.

What is the net financing of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its net financing of Cue Biopharma Inc was 26.29M, with a year-on-year change of 156.67.

What is the Earnings Per Share (EPS) of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.42, with a year-on-year change of -1066.66.

What is the net income of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its net income was -26.60M, with a year-on-year change of 34.60.

What is the net margin of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its net profit margin was -96.85, with a year-on-year change of 77.89.

What is the Return on Equity (ROE) of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -121.11, with a year-on-year change of 18.74.

What is the Return on Assets (ROA) of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -71.51, with a year-on-year change of 17.62.

What is the operating profit of Cue Biopharma Inc?

According to Cue Biopharma Inc's FY2025 earnings report, its operating profit was -26.52M, with a year-on-year change of 36.24.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.